|
NSUN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.3553000045039E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.893400E-01 |
| Stage1-vs-Stage3 |
2.446300E-02 |
| Stage1-vs-Stage4 |
3.80939999999885E-05 |
| Stage2-vs-Stage3 |
2.746300E-02 |
| Stage2-vs-Stage4 |
9.821700E-04 |
| Stage3-vs-Stage4 |
6.966500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.10169999789633E-08 |
| Normal-vs-Asian |
1.97974969751158E-12 |
| Caucasian-vs-AfricanAmerican |
5.160200E-01 |
| Caucasian-vs-Asian |
2.840400E-01 |
| AfricanAmerican-vs-Asian |
8.856600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
7.718200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.22044604925031E-15 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.552830E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.838600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.272800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.622800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.552400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.349400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.407800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.4952000000007E-05 |
| Classical-VS-Follicular |
1.846820E-01 |
| Classical-VS-Other |
1.928960E-01 |
| Classical-VS-Normal |
9.1926466438963E-14 |
| Tall-VS-Follicular |
4.04160000000431E-05 |
| Tall-VS-Other |
9.168000E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.339970E-01 |
| Follicular-VS-Normal |
2.22559748408457E-11 |
| Other-VS-Normal |
2.19189999999259E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
1.190080E-02 |
|
|
